Maximize product access by channelizing all managed markets stakeholders
Ensure commercial success across the brand portfolio while maintaining affordable quality of care.
Managed markets
The journey of a drug from the manufacturing unit into the patients’ hands is a long and complicated one. Every life sciences company wants to ensure unfettered market access to meet commercial objectives while ensuring the desired patient benefits. To do so, companies must ensure that they work closely with each of the managed markets forces for optimized product coverage, maximized market access, desired patient, and commercial outcomes.
Define the critical competitive advantage that could spell the difference between the real-world success or failure of life sciences products.
Affecting a patient’s access to desired treatments
Managed Market Forces
Commercial health plans and pharmacy benefit management (PBM)
Trade (wholesaler and specialty pharmacy)
Long-term care
organizations
Institutional (hospitals and clinics)
Government (federal and state) provisions and reimbursements
Pharma manufacturer
Factors influencing a patient’s access to pharma products
Patient
Axtria research hub
Blog
Evolution of Marketing-Mix Methodologies to Account for Managed Care Dynamics
Blog
What Managed Care Analytics Means to Pharma Brand Success – Part 2
Blog
What Managed Care Analytics Means to Pharma Brand Success – Part 1
Customer success stories
Case Study
Up To 10% Higher Return On Investment (ROI) From An Omnichannel-Led Digital Engagement For A Top Ten Pharma
Case Study
Data Analytics-driven Roster And Alignment Optimization For A Major Medtech Company
Case Study